PMCPA Case Library

1,752 PMCPA Rulings.
Every One Analysed.

The only structured, searchable PMCPA case library in the UK. Expert video walkthroughs, podcast episodes, and MCQ assessments on every ruling — so you understand why companies breach the Code, not just that they did.

▶ Video analysis per case
🎧 Podcast per case
✍ MCQ + CPD certificate
🔒 From £299/year
1752+
Case Studies
5 min
Per Video
5 pts
Per Case Passed
8
Themes
📚
Subscribe for full case library access
Read free summaries below, or subscribe to unlock expert video walkthroughs, podcast audio and CPD certificates.
Sign in See plans ↓
Free — Browsing
✓ Browse all 1752+ case titles
✓ Filter by theme & therapy area
✓ See case reference, company & outcome
✗ Search by company or clause
✗ Video walkthroughs
✗ Podcast episodes
✗ MCQ assessments & CPD certificates
Subscribed — Full Access
✓ Search by company, clause & case ref
✓ Expert video walkthrough per case
✓ Podcast episode per case
✓ MCQ quiz — 5 CPD points per pass
✓ Personalised CPD completion certificate
✓ New cases added monthly
Subscribe from £299/year →
Search by company, clause, case reference... 🔒
All (1752) Social Media & Digital (720) HCP Hospitality & Meetings (431) Data & Publications (321) Off-label Promotion (219) Patient Organisations (44) Transfers of Value (9) Promotional Material (4) Samples & Gifts (2)
Therapy Area: All areas Other (360) Oncology (218) Cardiovascular (189) Respiratory (178) CNS & Neurology (169) Infectious Diseases (115) Diabetes (114) Rare Diseases (104) Immunology & Rheumatology (84) Dermatology (67) Obesity & Weight Management (63) Musculoskeletal & Bone (60) Ophthalmology (31)
Showing 104 results · Rare Diseases  · Clear
🔒 Subscribers only
AUTH/3326/3/20
Off-label Promotion Upheld 🏥 Rare Diseases ▶ Video 🎙 Podcast
Norgine
Norgine made claims for Feraccru (oral ferric maltol) including: “In the new head-to-head trial, Feraccru was found to be non-inferior to IV ferric carboxymaltose” and “Feraccru may be an app…
Clauses: 9.1,9.2
2020 🔒 Subscribe
🔒 Subscribers only
AUTH/3370/8/20
Social Media & Digital Not Upheld 🏥 Rare Diseases ▶ Video 🎙 Podcast
Ferring
A UK health professional complained that a Ferring-commissioned/sponsored supplement (“Trends Urology and Men’s Health”) was still available online despite stating it would be hosted only unt…
Clauses: NONE
2020 🔒 Subscribe
🔒 Subscribers only
AUTH/3369/8/20
Social Media & Digital Not Upheld 🏥 Rare Diseases ▶ Video 🎙 Podcast
Pfizer
A UK health professional complained about two Ecalta (anidulafungin) leavepieces (refs ECA359 and PP-ERA-GBR-0169) found online via Google search results and direct links referencing the Pfizerpro …
Clauses: NONE
2020 🔒 Subscribe
🔒 Subscribers only
AUTH/3274/10/19
Social Media & Digital Upheld 🏥 Rare Diseases ▶ Video 🎙 Podcast
Diurnal
A “concerned UK health professional” complained about a Diurnal corporate website page in the health professionals section.The page combined “Products and Pipeline” content and included a t…
2019 🔒 Subscribe
🔒 Subscribers only
AUTH/3159/2/19
Data & Publications Not Upheld 🏥 Rare Diseases ▶ Video 🎙 Podcast
Vifor
Pharmacosmos complained that Vifor medical personnel proactively contacted UK health professionals to discuss safety data from Ehlken et al (2018) about severe hypersensitivity reactions, comparing…
Clauses: NONE
2019 🔒 Subscribe
🔒 Subscribers only
AUTH/3217/6/19
Social Media & Digital Not Upheld 🏥 Rare Diseases ▶ Video 🎙 Podcast
Otsuka
A health professional complained that Otsuka’s Jinarc (tolvaptan) training website for UK health professionals was promotional but did not meet Code requirements for promotional material.The comp…
Clauses: NONE
2019 🔒 Subscribe
🔒 Subscribers only
AUTH/3231/7/19
Social Media & Digital Not Upheld 🏥 Rare Diseases ▶ Video 🎙 Podcast
Shield and Norgine
A UK health professional complained about content on the Feraccru (ferric maltol) website (Feraccru used to treat adults with iron deficiency).The website stated “Feraccru is well tolerated”, w…
Clauses: NONE
2019 🔒 Subscribe
🔒 Subscribers only
AUTH/3184/4/19
Social Media & Digital Not Upheld 🏥 Rare Diseases ▶ Video 🎙 Podcast
GW Pharmaceuticals website
A “concerned UK health professional” complained about GW Pharmaceuticals’ UK corporate website (gwpharm.co.uk).GW was the marketing authorisation holder (MAH) of Sativex; in the UK, Sativex w…
Clauses: NONE
2019 🔒 Subscribe
🔒 Subscribers only
AUTH/3163/2/19
Social Media & Digital Not Upheld 🏥 Rare Diseases ▶ Video 🎙 Podcast
Alexion
A UK health professional complained about a LinkedIn post seen in their feed, originally raised in an earlier case (AUTH/3051/6/18).The post (from Alexion’s US parent account) stated Alexion had …
Clauses: NONE
2019 🔒 Subscribe
🔒 Subscribers only
AUTH/3266/10/19
Social Media & Digital Not Upheld 🏥 Rare Diseases ▶ Video 🎙 Podcast
Otsuka UK/Otsuka Europe
A health professional complained about two online press releases concerning ASTX727 (oral cedazuridine/decitabine fixed-dose combination) being studied for MDS including CMML.Press release 1 (seen …
Clauses: NONE
2019 🔒 Subscribe
🔒 Subscribers only
AUTH/3227/7/19
Social Media & Digital Not Upheld 🏥 Rare Diseases ▶ Video 🎙 Podcast
Ferring v Pharmasure
Ferring complained about a Pharmasure Meriofert (menotrophin) detail aid (ref UK/201809/00001/01) and noted similar claims on the Pharmasure UK website (UK/201810/00005/01).The material compared Me…
Clauses: NONE
2019 🔒 Subscribe
🔒 Subscribers only
AUTH/3259/10/19
Data & Publications Not Upheld 🏥 Rare Diseases ▶ Video 🎙 Podcast
Otsuka Europe
An employee complained about Otsuka Europe regarding EU risk minimisation plan (RMP) / additional risk minimisation measures (aRMM) materials for Jinarc (tolvaptan), alleging patient safety risk an…
Clauses: NONE
2019 🔒 Subscribe
🔒 Subscribers only
AUTH/3037/4/18
Social Media & Digital Not Upheld 🏥 Rare Diseases ▶ Video 🎙 Podcast
Shield Therapeutics
An anonymous UK health professional complained about content on Shield Therapeutics’ corporate website relating to Feraccru (ferric maltol) and pipeline products PT20, PT30 and PT40.The complaina…
Clauses: NONE
2018 🔒 Subscribe
🔒 Subscribers only
AUTH/3096/9/18
Data & Publications Not Upheld 🏥 Rare Diseases ▶ Video 🎙 Podcast
AUTH/3096/9/18 Director v Shire
Clauses: NONE
2018 🔒 Subscribe
🔒 Subscribers only
AUTH/3088/9/18
Social Media & Digital Not Upheld 🏥 Rare Diseases ▶ Video 🎙 Podcast
Ipsen
The PMCPA Director initiated a complaint (under Paragraph 5.1) after a BMJ paper (Goldacre et al, published online 12 September 2018) assessed whether sponsors posted due trial results to the EU Cl…
Clauses: NONE
2018 🔒 Subscribe
🔒 Subscribers only
AUTH/3051/6/18
Social Media & Digital Not Upheld 🏥 Rare Diseases ▶ Video 🎙 Podcast
Alexion
A UK health professional complained about a LinkedIn post appearing in their feed from Alexion Pharmaceuticals, linking to a press release about ALXN1210 (PNH) and EU regulatory submission.The comp…
Clauses: NONE
2018 🔒 Subscribe
🔒 Subscribers only
AUTH/3100/9/18
Data & Publications Not Upheld 🏥 Rare Diseases ▶ Video 🎙 Podcast
Pierre Fabre
A complaint was made by the Director against Pierre Fabre.The subject matter related to clinical trial disclosure.The PMCPA determined the matter was outwith the scope of the ABPI Code (Applicable …
Clauses: NONE
2018 🔒 Subscribe
🔒 Subscribers only
AUTH/3095/9/18
Data & Publications Not Upheld 🏥 Rare Diseases ▶ Video 🎙 Podcast
Actelion
A complaint was made by the Director against Actelion.The subject matter related to clinical trial disclosure.The PMCPA determined the matter was outwith the scope of the ABPI Code of Practice (App…
Clauses: NONE
2018 🔒 Subscribe
🔒 Subscribers only
AUTH/3092/9/18
Data & Publications Not Upheld 🏥 Rare Diseases ▶ Video 🎙 Podcast
Celgene
A complaint was brought by the Director against Celgene.The subject matter related to clinical trial disclosure.The PMCPA determined the matter was outwith the scope of the ABPI Code (2016).
Clauses: NONE
2018 🔒 Subscribe
🔒 Subscribers only
AUTH/3018/2/18
Data & Publications Upheld 🏥 Rare Diseases ▶ Video 🎙 Podcast
Tesaro
Tesaro UK identified (via an internal email in Feb 2018) that seven hard-copy promotional items for Zejula (niraparib) might have been distributed to the field team before certification of their fi…
Clauses: 9.1
2018 🔒 Subscribe
🔒 Subscribers only
AUTH/3014/1/18
HCP Hospitality & Meetings Not Upheld 🏥 Rare Diseases ▶ Video 🎙 Podcast
GW Pharmaceuticals
An anonymous, non-contactable complainant (self-described health professional) alleged GW Pharmaceuticals promoted Epidiolex (cannabidiol) at the British Paediatric Neurology Association (BPNA) mee…
Clauses: NONE
2018 🔒 Subscribe
🔒 Subscribers only
AUTH/2986/10/17
Social Media & Digital Not Upheld 🏥 Rare Diseases ▶ Video 🎙 Podcast
Teva representative email to private hospital deemed misleading about status (AUTH/2986/10/17)
An anonymous, non-contactable complainant alleged that (July–Oct 2017) a Teva account manager contacted/visited a private hospital and falsely presented him/herself as an authorised adviser/speci…
Clauses: NONE
2017 🔒 Subscribe
🔒 Subscribers only
AUTH/2984/10/17
Data & Publications Not Upheld 🏥 Rare Diseases ▶ Video 🎙 Podcast
Astellas UK
A hospital doctor alleged Astellas UK inappropriately awarded research funding (~£250,000) in 2009 in association with use of Advagraf (tacrolimus) in a renal transplant protocol (Advagraf de novo…
Clauses: NONE
2017 🔒 Subscribe
🔒 Subscribers only
AUTH/3007/12/17
Data & Publications Not Upheld 🏥 Rare Diseases ▶ Video 🎙 Podcast
Vifor Fresenius
The PMCPA Director reviewed a matter relating to clinical trial disclosure for Velphoro involving Vifor Fresenius.The review was assessed under the ABPI Code of Practice (Applicable Code year: 2016…
Clauses: NONE
2017 🔒 Subscribe
← Prev 1 2 3 4 5 Next → Page 2 of 5 — 104 cases
Unlock the Full Case Library
Annual subscription — instant access, cancel anytime.
🏆
The only PMCPA case library of its kind
No other provider publishes a structured, searchable library of PMCPA rulings with video and podcast. A single half-day compliance workshop from a specialist provider typically costs £499+ — for one session. Individual access here is £299 for a full year of 2,000+ cases.
PMCPA Case Library — Team (100 seats)
Custom pricing
tailored to your team size
Bulk pricing available — contact us for a quote
Enquire for bulk pricing →
Individual
For a single learner
£299
per year
Less than a single half-day workshop
  • 1 user seat
  • All 1752+ case studies
  • Video + podcast per case
  • MCQ quiz per case
  • 5 points per case passed
  • New cases added monthly
Create account or sign in to buy
Most Popular
Team 5
Up to 5 team members
£999
per year (£200/seat)
£200/person — the most cost-effective team option
  • 5 user seats
  • All case studies included
  • Video, podcast & MCQ per case
  • Team progress dashboard
  • New cases added monthly
  • Admin management portal
Create account or sign in to buy
Team 25+
25+ team members
Custom pricing
tailored to your team size
Bulk pricing available — contact us for a quote
  • 25 user seats
  • All case studies included
  • Video, podcast & MCQ per case
  • Team progress dashboard
  • Bulk seat management
  • Priority support
Enquire for bulk pricing →

Questions? Email [email protected]  ·  14-day money-back guarantee  ·  Annual subscription, auto-renews